Concepedia

Elvire Roblin

ER

3

Publications

306

Citations

3

H-Index

2020

Active since

Affiliations

Inserm(Current)

Institut Gustave Roussy

University of Padua

Istituto Oncologico Veneto

Indiana University – Purdue University Indianapolis

Elvire Roblin is an author at Inserm specializing in cancer therapeutics, immunotherapy, and pathology.

ORCID

Top concepts

Publications per year

2020–2022

3

Publications

3

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim et al. · npj Breast Cancer · 2020 · 190 citations · Full text

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer

Sherene Loi, Roberto Salgado, Sylvia Adams et al. · npj Breast Cancer · 2022 · 76 citations · Full text

High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy

Laurent Dercle, Samy Ammari, Elvire Roblin et al. · European Journal of Cancer · 2022 · 40 citations

, , +9

Rows per page

1–3 of 3